Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A in Foot and Ankle Muscular Disorders
IRCT20200521047525N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in muscle disorder and Muscle spasm, sponsored by Shahid Beheshti University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
muscle disorderMuscle spasm
Beyond the preview
Go deeper on IRCT20200521047525N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200521047525N2.